Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.776 EUR | -2.27% | -1.77% | +0.78% |
May. 30 | Futures bearish; focus on European data | AN |
May. 29 | Stock markets in the red; DiaSorin snap on Mib. | AN |
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.42 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 79.4 times its estimated earnings per share for the ongoing year.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Advertising & Marketing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.78% | 23.96M | - | ||
+7.46% | 18.2B | B+ | ||
+0.32% | 12.64B | C- | ||
-3.86% | 11.84B | B | ||
+9.88% | 11.15B | A- | ||
+20.33% | 5.04B | A- | ||
+1.21% | 3.44B | C+ | ||
-21.66% | 3.35B | - | C- | |
+17.89% | 3.13B | B | ||
+9.06% | 3.04B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TB Stock
- Ratings Triboo S.p.A.